CHARACTERIZATION OF THE 14 KDA FRAGMENT OF HUMAN TUMOR-NECROSIS-FACTOR-ALPHA
- JK SAGOO
- C IAONNOU
- NRA BEELEY
- C SUTTON
- CI DEMATTEIS
- SJB TENDLER
Affiliations: UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,BIOPHYS & SURFACE ANAL LAB,NOTTINGHAM NG7 2RD,ENGLAND. CELLTECH LTD,SLOUGH SL1 4EN,BERKS,ENGLAND. FINNIGAN MAT CORP,HEMEL HEMPSTEAD HP2 4TG,HERTS,ENGLAND.
- Published online on: December 1, 1995 https://doi.org/10.3892/ijo.7.6.1437
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
We report the characterization of a 14 kDa degradation fragment from recombinant human tumour necrosis factor-alpha (TNF alpha) by N-terminal sequencing and mass spectrometry. A single site between the dibasic residues Arg(31)-Arg(32) of the mature recombinant 17 kDa protein has been identified as the target site that generates the 14 kDa fragment. The observation that a maximum of 33% degradation occurs suggests that only one monomer per TNF trimer is cleaved. E. coli proteases specific for dibasic residues are thought to be responsible for this cleavage. A strategy has been developed which completely inhibits proteolysis. This strategy has been used to reduce the 14 kDa degradation fragment obtained from approximately 33% of the total purified protein to zero.